Rights and permissions
About this article
Cite this article
Gemcitabine alone or in combination with cisplatin cost effective in NSCLC. Pharmacoecon. Outcomes News 363, 7 (2002). https://doi.org/10.1007/BF03279079
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279079